- Home
- BTAI vs MAMK Comparison
BTAI vs MAMK Comparison
Compare BTAI & MAMK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- MAMK
- Stock Information
- Founded
- BTAI 2017
- MAMK 2007
- Country
- BTAI United States
- MAMK China
- Employees
- BTAI N/A
- MAMK N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- MAMK Apparel
- Sector
- BTAI Health Care
- MAMK Consumer Discretionary
- Exchange
- BTAI Nasdaq
- MAMK Nasdaq
- Market Cap
- BTAI 48.3M
- MAMK 52.9M
- IPO Year
- BTAI 2018
- MAMK 2025
- Fundamental
- Price
- BTAI $2.05
- MAMK $4.85
- Analyst Decision
- BTAI Buy
- MAMK
- Analyst Count
- BTAI 5
- MAMK 0
- Target Price
- BTAI $32.80
- MAMK N/A
- AVG Volume (30 Days)
- BTAI 987.3K
- MAMK 892.4K
- Earning Date
- BTAI 11-12-2025
- MAMK 02-18-2026
- Dividend Yield
- BTAI N/A
- MAMK N/A
- EPS Growth
- BTAI N/A
- MAMK N/A
- EPS
- BTAI N/A
- MAMK N/A
- Revenue
- BTAI $868,000.00
- MAMK $24,104,331.00
- Revenue This Year
- BTAI N/A
- MAMK N/A
- Revenue Next Year
- BTAI $614.78
- MAMK N/A
- P/E Ratio
- BTAI N/A
- MAMK $77.78
- Revenue Growth
- BTAI N/A
- MAMK N/A
- 52 Week Low
- BTAI $1.17
- MAMK $1.87
- 52 Week High
- BTAI $12.16
- MAMK $12.78
- Technical
- Relative Strength Index (RSI)
- BTAI 34.65
- MAMK N/A
- Support Level
- BTAI $2.14
- MAMK N/A
- Resistance Level
- BTAI $2.46
- MAMK N/A
- Average True Range (ATR)
- BTAI 0.16
- MAMK 0.00
- MACD
- BTAI -0.00
- MAMK 0.00
- Stochastic Oscillator
- BTAI 9.03
- MAMK 0.00
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About MAMK MaxsMaking Inc. Class A Ordinary Shares
MaxsMaking Inc is a manufacturer of consumer goods with a focus on technology and innovation. It is serving small and medium-sized enterprises and individual e-commerce sellers with their needs for small batch products, It currently use cotton cloth, nylon cloth, polyester, recycled polyethylene terephthalate (rPET) and other materials to produce backpacks, shopping bags, aprons, tablecloths and other consumer goods. It serve enterprises, schools, government agencies, non-profit organizations, e-commerce sellers and various groups and organizations to meet their needs for small-batch products.